Please enable JavaScript to continue using this application.

Compare $CBUS vs $TNXP | Chartloom

Compare

$CBUS vs $TNXP

Cibus Inc · Tonix Pharmaceuticals Holding Corp

CBUS

Cibus Inc

TNXP

Tonix Pharmaceuticals Holding Corp

Compare $CBUS vs $TNXP

Comparing Cibus Inc and Tonix Pharmaceuticals Holding Corp

CBUSCibus Inc

TNXPTonix Pharmaceuticals Holding Corp

CBUSCibus Inc

Market cap

$118M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.82x

Rev growth (TTM)

-10.3%

YTD performance

-17.6%

52W performance

5.4%

FCF yield

-39.2%

TNXPTonix Pharmaceuticals Holding Corp

Market cap

$116M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.39x

Rev growth (TTM)

196.0%

YTD performance

-55.9%

52W performance

-67.5%

FCF yield

-135.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CBUS

TNXP

Detailed metrics comparison

CBUS

Cibus Inc

TNXP

Tonix Pharmaceuticals Holding Corp

Market Cap

CBUS$118M

TNXP$116M

Enterprise Value

CBUS$352M

TNXP$-60M

Price

CBUS$1.55

TNXP$7.30

P/E Ratio

CBUSN/A

TNXPN/A

P/S Ratio

CBUS27.22x

TNXP4.00x

EV/Sales

CBUS81.04x

TNXP-2.06x

EV/EBITDA

CBUS0.00x

TNXP0.00x

P/B Ratio

CBUS8.83x

TNXP0.69x

P/FCF Ratio

CBUSN/A

TNXPN/A

EV/FCF

CBUS-7.59x

TNXP0.38x

PEG Ratio

CBUSN/A

TNXPN/A

Forward P/E (NTM)

CBUSN/A

TNXPN/A

Forward P/S (NTM)

CBUS12.82x

TNXP1.39x

Revenue (TTM)

CBUS$4M

TNXP$29M

Revenue Growth (YoY)

CBUS-10.3%

TNXP196.0%

Forward Rev Growth

CBUS139.3%

TNXP101.6%

Gross Margin (TTM)

CBUS100.0%

TNXP83.8%

Operating Margin (TTM)

CBUS0.0%

TNXP0.0%

EBITDA Margin (TTM)

CBUS-1124.2%

TNXP-561.1%

Net Margin (TTM)

CBUS-2258.9%

TNXP-548.6%

FCF Margin (TTM)

CBUS-1067.5%

TNXP-543.3%

Net Income (TTM)

CBUS$-98M

TNXP$-160M

FCF (TTM)

CBUS$-46M

TNXP$-158M

EPS (TTM)

CBUS-$1.28

TNXP-$9.60

ROE (TTM)

CBUS-32060.0%

TNXP-6899.0%

ROA (TTM)

CBUS-3086.0%

TNXP-6132.0%

ROIC (TTM)

CBUS-3627.0%

TNXP-6899.0%

Cash

CBUS$20M

TNXP$176M

Debt

CBUS$254M

TNXP$0

Net Cash/Debt

CBUS$-234M

TNXP$176M

Current Ratio (TTM)

CBUS1.62x

TNXP6.61x

Quick Ratio (TTM)

CBUS1.47x

TNXP6.13x

Debt/Equity (TTM)

CBUS17.19x

TNXP0.00x

Debt/Assets (TTM)

CBUS0.0%

TNXP0.0%

Interest Coverage (TTM)

CBUSN/A

TNXPN/A

Net Debt/EBITDA (TTM)

CBUS0.00x

TNXP0.00x

Beta

CBUS1.70

TNXP1.87

52W Performance

CBUS5.4%

TNXP-67.5%

YTD Performance

CBUS-17.6%

TNXP-55.9%

% from 52W High

CBUS-63.0%

TNXP-68.3%

% from 52W Low

CBUS42.2%

TNXP3.0%

Asset Turnover (TTM)

CBUS0.01x

TNXP0.11x

FCF Yield (TTM)

CBUS-39.2%

TNXP-135.9%

Earnings Yield (TTM)

CBUS-83.0%

TNXP-137.2%

Dividend Yield (TTM)

CBUSN/A

TNXPN/A

Rule of 40

CBUS-1,077.8

TNXP-347.3

EV/GP/RG

CBUS0.72

TNXPN/A

Ticker research

View CBUS research View TNXP research

Metric	CBUS Cibus Inc	TNXP Tonix Pharmaceuticals Holding Corp
Market & Valuation
Market Cap	$118M	$116M
Enterprise Value	$352M	$-60M
Price	$1.55	$7.30
P/E Ratio	N/A	N/A
P/S Ratio	27.22x	4.00x
EV/Sales	81.04x	-2.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.83x	0.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.59x	0.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.82x	1.39x
Revenue & Growth
Revenue (TTM)	$4M	$29M
Revenue Growth (YoY)	-10.3%	196.0%
Forward Rev Growth	139.3%	101.6%
Profitability
Gross Margin (TTM)	100.0%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1124.2%	-561.1%
Net Margin (TTM)	-2258.9%	-548.6%
FCF Margin (TTM)	-1067.5%	-543.3%
Net Income (TTM)	$-98M	$-160M
FCF (TTM)	$-46M	$-158M
EPS (TTM)	-$1.28	-$9.60
ROE (TTM)	-32060.0%	-6899.0%
ROA (TTM)	-3086.0%	-6132.0%
ROIC (TTM)	-3627.0%	-6899.0%
Financial Health
Cash	$20M	$176M
Debt	$254M	$0
Net Cash/Debt	$-234M	$176M
Current Ratio (TTM)	1.62x	6.61x
Quick Ratio (TTM)	1.47x	6.13x
Debt/Equity (TTM)	17.19x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.70	1.87
52W Performance	5.4%	-67.5%
YTD Performance	-17.6%	-55.9%
% from 52W High	-63.0%	-68.3%
% from 52W Low	42.2%	3.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.11x
FCF Yield (TTM)	-39.2%	-135.9%
Earnings Yield (TTM)	-83.0%	-137.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,077.8	-347.3
EV/GP/RG	0.72	N/A
Ticker research	View CBUS research	View TNXP research

Valuation

P/S Ratio

TNXP

4.00x

CBUS

27.22x

EV/FCF

CBUS

-7.59x

TNXP

0.38x

Growth & revenue

Revenue Growth TTM

TNXP

196.0%

CBUS

-10.3%

Forward Revenue Growth

CBUS

139.3%

TNXP

101.6%

Profitability & performance

Gross Margin

CBUS

100.0%

TNXP

83.8%

ROE

TNXP

-6899.0%

CBUS

-32060.0%

FCF Yield %

CBUS

-39.2%

TNXP

-135.9%

52-Week Performance

CBUS

5.4%

TNXP

-67.5%

Detailed metrics comparison

CBUS

Cibus Inc

TNXP

Tonix Pharmaceuticals Holding Corp

Market Cap

CBUS$118M

TNXP$116M

Enterprise Value

CBUS$352M

TNXP$-60M

Price

CBUS$1.55

TNXP$7.30

P/E Ratio

CBUSN/A

TNXPN/A

P/S Ratio

CBUS27.22x

TNXP4.00x

EV/Sales

CBUS81.04x

TNXP-2.06x

EV/EBITDA

CBUS0.00x

TNXP0.00x

P/B Ratio

CBUS8.83x

TNXP0.69x

P/FCF Ratio

CBUSN/A

TNXPN/A

EV/FCF

CBUS-7.59x

TNXP0.38x

PEG Ratio

CBUSN/A

TNXPN/A

Forward P/E (NTM)

CBUSN/A

TNXPN/A

Forward P/S (NTM)

CBUS12.82x

TNXP1.39x

Revenue (TTM)

CBUS$4M

TNXP$29M

Revenue Growth (YoY)

CBUS-10.3%

TNXP196.0%

Forward Rev Growth

CBUS139.3%

TNXP101.6%

Gross Margin (TTM)

CBUS100.0%

TNXP83.8%

Operating Margin (TTM)

CBUS0.0%

TNXP0.0%

EBITDA Margin (TTM)

CBUS-1124.2%

TNXP-561.1%

Net Margin (TTM)

CBUS-2258.9%

TNXP-548.6%

FCF Margin (TTM)

CBUS-1067.5%

TNXP-543.3%

Net Income (TTM)

CBUS$-98M

TNXP$-160M

FCF (TTM)

CBUS$-46M

TNXP$-158M

EPS (TTM)

CBUS-$1.28

TNXP-$9.60

ROE (TTM)

CBUS-32060.0%

TNXP-6899.0%

ROA (TTM)

CBUS-3086.0%

TNXP-6132.0%

ROIC (TTM)

CBUS-3627.0%

TNXP-6899.0%

Cash

CBUS$20M

TNXP$176M

Debt

CBUS$254M

TNXP$0

Net Cash/Debt

CBUS$-234M

TNXP$176M

Current Ratio (TTM)

CBUS1.62x

TNXP6.61x

Quick Ratio (TTM)

CBUS1.47x

TNXP6.13x

Debt/Equity (TTM)

CBUS17.19x

TNXP0.00x

Debt/Assets (TTM)

CBUS0.0%

TNXP0.0%

Interest Coverage (TTM)

CBUSN/A

TNXPN/A

Net Debt/EBITDA (TTM)

CBUS0.00x

TNXP0.00x

Beta

CBUS1.70

TNXP1.87

52W Performance

CBUS5.4%

TNXP-67.5%

YTD Performance

CBUS-17.6%

TNXP-55.9%

% from 52W High

CBUS-63.0%

TNXP-68.3%

% from 52W Low

CBUS42.2%

TNXP3.0%

Asset Turnover (TTM)

CBUS0.01x

TNXP0.11x

FCF Yield (TTM)

CBUS-39.2%

TNXP-135.9%

Earnings Yield (TTM)

CBUS-83.0%

TNXP-137.2%

Dividend Yield (TTM)

CBUSN/A

TNXPN/A

Rule of 40

CBUS-1,077.8

TNXP-347.3

EV/GP/RG

CBUS0.72

TNXPN/A

Ticker research

View CBUS research View TNXP research

Metric	CBUS Cibus Inc	TNXP Tonix Pharmaceuticals Holding Corp
Market & Valuation
Market Cap	$118M	$116M
Enterprise Value	$352M	$-60M
Price	$1.55	$7.30
P/E Ratio	N/A	N/A
P/S Ratio	27.22x	4.00x
EV/Sales	81.04x	-2.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.83x	0.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.59x	0.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.82x	1.39x
Revenue & Growth
Revenue (TTM)	$4M	$29M
Revenue Growth (YoY)	-10.3%	196.0%
Forward Rev Growth	139.3%	101.6%
Profitability
Gross Margin (TTM)	100.0%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1124.2%	-561.1%
Net Margin (TTM)	-2258.9%	-548.6%
FCF Margin (TTM)	-1067.5%	-543.3%
Net Income (TTM)	$-98M	$-160M
FCF (TTM)	$-46M	$-158M
EPS (TTM)	-$1.28	-$9.60
ROE (TTM)	-32060.0%	-6899.0%
ROA (TTM)	-3086.0%	-6132.0%
ROIC (TTM)	-3627.0%	-6899.0%
Financial Health
Cash	$20M	$176M
Debt	$254M	$0
Net Cash/Debt	$-234M	$176M
Current Ratio (TTM)	1.62x	6.61x
Quick Ratio (TTM)	1.47x	6.13x
Debt/Equity (TTM)	17.19x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.70	1.87
52W Performance	5.4%	-67.5%
YTD Performance	-17.6%	-55.9%
% from 52W High	-63.0%	-68.3%
% from 52W Low	42.2%	3.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.11x
FCF Yield (TTM)	-39.2%	-135.9%
Earnings Yield (TTM)	-83.0%	-137.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,077.8	-347.3
EV/GP/RG	0.72	N/A
Ticker research	View CBUS research	View TNXP research